JP2013505265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013505265A5 JP2013505265A5 JP2012529958A JP2012529958A JP2013505265A5 JP 2013505265 A5 JP2013505265 A5 JP 2013505265A5 JP 2012529958 A JP2012529958 A JP 2012529958A JP 2012529958 A JP2012529958 A JP 2012529958A JP 2013505265 A5 JP2013505265 A5 JP 2013505265A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cdcl
- nmr
- mhz
- procedure similar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24429709P | 2009-09-21 | 2009-09-21 | |
| US61/244,297 | 2009-09-21 | ||
| PCT/US2010/049471 WO2011035231A1 (en) | 2009-09-21 | 2010-09-20 | 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015098728A Division JP6033362B2 (ja) | 2009-09-21 | 2015-05-14 | 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013505265A JP2013505265A (ja) | 2013-02-14 |
| JP2013505265A5 true JP2013505265A5 (enExample) | 2014-12-25 |
| JP5795766B2 JP5795766B2 (ja) | 2015-10-14 |
Family
ID=43031517
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012529958A Active JP5795766B2 (ja) | 2009-09-21 | 2010-09-20 | 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体 |
| JP2015098728A Active JP6033362B2 (ja) | 2009-09-21 | 2015-05-14 | 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体 |
| JP2016207475A Withdrawn JP2017075146A (ja) | 2009-09-21 | 2016-10-24 | 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015098728A Active JP6033362B2 (ja) | 2009-09-21 | 2015-05-14 | 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体 |
| JP2016207475A Withdrawn JP2017075146A (ja) | 2009-09-21 | 2016-10-24 | 抗ウイルス治療のための２′−フルオロ置換カルバ−ヌクレオシド類似体 |
Country Status (32)
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3237884B2 (ja) | 1991-12-27 | 2001-12-10 | 株式会社コーセー | 美爪料 |
| HUE025528T2 (en) | 2008-04-23 | 2016-05-30 | Gilead Sciences Inc | 1'-substituted carba-nucleoside analogs for antiviral treatment |
| US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| US8716263B2 (en) | 2008-12-23 | 2014-05-06 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
| US8551973B2 (en) | 2008-12-23 | 2013-10-08 | Gilead Pharmasset Llc | Nucleoside analogs |
| PA8855601A1 (es) | 2008-12-23 | 2010-07-27 | Forformidatos de nucleósidos | |
| US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
| TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
| ME01528B (me) * | 2009-09-21 | 2014-04-20 | Gilead Sciences Inc | POSTUPCI l INTERMEDIJERI ZA PROIZVODNJU 1'-CIJANOKARBANUKLEOZIDIH ANALOGA |
| MX352646B (es) * | 2009-09-21 | 2017-12-04 | Gilead Sciences Inc | Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral. |
| US7973013B2 (en) * | 2009-09-21 | 2011-07-05 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| US8455451B2 (en) | 2009-09-21 | 2013-06-04 | Gilead Sciences, Inc. | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| WO2011123668A2 (en) | 2010-03-31 | 2011-10-06 | Pharmasset, Inc. | Stereoselective synthesis of phosphorus containing actives |
| TW201201815A (en) * | 2010-05-28 | 2012-01-16 | Gilead Sciences Inc | 1'-substituted-carba-nucleoside prodrugs for antiviral treatment |
| EP2805960A1 (en) | 2010-07-19 | 2014-11-26 | Gilead Sciences, Inc. | Methods for the preparation of diasteromerically pure phosphoramidate prodrugs |
| US20120027752A1 (en) | 2010-07-22 | 2012-02-02 | Gilead Sciences, Inc. | Methods and compounds for treating paramyxoviridae virus infections |
| TW201305185A (zh) * | 2010-09-13 | 2013-02-01 | Gilead Sciences Inc | 用於抗病毒治療之２’－氟取代之碳－核苷類似物 |
| EA026523B1 (ru) * | 2010-09-20 | 2017-04-28 | Джилид Сайэнс, Инк. | 2'-фторзамещенные карбануклеозидные аналоги для противовирусного лечения |
| EA201691695A1 (ru) | 2010-11-19 | 2017-11-30 | Джилид Сайэнс, Инк. | Терапевтические композиции, содержащие рилпивирин hcl и тенофовира дизопроксилфумарат |
| NZ613370A (en) | 2010-12-20 | 2015-05-29 | Gilead Sciences Inc | Combinations for treating hcv |
| AR088441A1 (es) * | 2011-09-12 | 2014-06-11 | Idenix Pharmaceuticals Inc | Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales |
| SMT201800087T1 (it) | 2011-09-16 | 2018-03-08 | Gilead Pharmasset Llc | Metodi per trattare hcv |
| EP2768838A1 (en) | 2011-10-14 | 2014-08-27 | IDENIX Pharmaceuticals, Inc. | Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
| KR102068856B1 (ko) | 2012-03-13 | 2020-01-21 | 길리애드 사이언시즈, 인코포레이티드 | 항바이러스 치료를 위한 2'-치환된 카바-뉴클레오시드 유사체 |
| AR092959A1 (es) | 2012-10-17 | 2015-05-06 | Merck Sharp & Dohme | Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
| WO2014059902A1 (en) * | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | 2'-disubstituted substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases |
| US9242988B2 (en) | 2012-10-17 | 2016-01-26 | Merck Sharp & Dohme Corp. | 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
| AU2013344757A1 (en) | 2012-11-19 | 2015-05-21 | Merck Sharp & Dohme Corp. | 2 -alkynyl substituted nucleoside derivatives for treating viral diseases |
| EA029081B9 (ru) | 2013-01-31 | 2018-09-28 | Джилид Фармассет Ллс | Комбинированный состав двух противовирусных соединений |
| EP3010512B1 (en) | 2013-06-18 | 2017-12-27 | Merck Sharp & Dohme Corp. | Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
| UA119050C2 (uk) | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| US10683321B2 (en) | 2013-12-18 | 2020-06-16 | Idenix Pharmaceuticals Llc | 4′-or nucleosides for the treatment of HCV |
| TWI678369B (zh) | 2014-07-28 | 2019-12-01 | 美商基利科學股份有限公司 | 用於治療呼吸道合胞病毒感染之噻吩並［３,２-ｄ］嘧啶、呋喃並［３,２-ｄ］嘧啶及吡咯並［３,２-ｄ］嘧啶化合物類 |
| US10526363B2 (en) | 2014-08-15 | 2020-01-07 | Merck Sharp & Dohme Corp. | Substituted phosphoramidate compounds and uses thereof |
| TWI673283B (zh) | 2014-08-21 | 2019-10-01 | 美商基利科學股份有限公司 | ２’－氯胺基嘧啶酮及嘧啶二酮核苷類 |
| TWI767201B (zh) | 2014-10-29 | 2022-06-11 | 美商基利科學股份有限公司 | 絲狀病毒科病毒感染之治療 |
| LT3236972T (lt) | 2014-12-26 | 2021-11-10 | Emory University | Antivirusiniai n4-hidroksicitidino dariniai |
| WO2016160646A1 (en) | 2015-04-02 | 2016-10-06 | Merck Sharp & Dohme Corp. | Process for making phosphoramidate protected nucleoside compounds |
| CN104945437B (zh) * | 2015-05-19 | 2017-03-01 | 广州诺威生物技术有限公司 | 一种嘧啶类新化合物 |
| HRP20220355T1 (hr) | 2015-09-16 | 2022-05-13 | Gilead Sciences, Inc. | Postupci za liječenje infekcija coronaviridae |
| WO2017156262A1 (en) | 2016-03-09 | 2017-09-14 | Alios Biopharma, Inc. | Acyclic antivirals |
| EP3436461B1 (en) | 2016-03-28 | 2023-11-01 | Incyte Corporation | Pyrrolotriazine compounds as tam inhibitors |
| CN106083962B (zh) * | 2016-06-08 | 2018-12-18 | 成都倍特药业有限公司 | 一种具有环磷酰胺结构的化合物及其制备方法 |
| US10202412B2 (en) | 2016-07-08 | 2019-02-12 | Atea Pharmaceuticals, Inc. | β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections |
| CN109476668B (zh) * | 2016-07-14 | 2022-03-22 | 豪夫迈·罗氏有限公司 | 用于治疗感染性疾病的6,7-二氢-4H-吡唑并[1,5-a]吡嗪和6,7-二氢-4H-三唑并[1,5-a]吡嗪化合物 |
| TW201811339A (zh) * | 2016-08-12 | 2018-04-01 | 美商艾洛斯生物製藥公司 | 經取代之核苷、核苷酸及其類似物 |
| JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| TW201836615A (zh) | 2017-03-14 | 2018-10-16 | 美商基利科學股份有限公司 | 治療貓冠狀病毒感染之方法 |
| CA3059777C (en) | 2017-05-01 | 2023-02-21 | Gilead Sciences, Inc. | Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate |
| WO2019014247A1 (en) | 2017-07-11 | 2019-01-17 | Gilead Sciences, Inc. | COMPOSITIONS COMPRISING POLYMERASE RNA INHIBITOR AND CYCLODEXTRIN FOR THE TREATMENT OF VIRAL INFECTIONS |
| KR102696517B1 (ko) * | 2017-09-18 | 2024-08-21 | 얀센 바이오파마, 인크. | 치환된 뉴클레오시드, 뉴클레오티드 및 이들의 유사체 |
| LT3706762T (lt) | 2017-12-07 | 2024-12-27 | Emory University | N4-hidroksicitidinas ir jo dariniai bei susiję naudojimo prieš virusus būdai |
| CA3091142C (en) | 2018-02-26 | 2023-04-11 | Gilead Sciences, Inc. | Substituted pyrrolizine compounds and uses thereof |
| EP3921319B1 (en) | 2019-02-07 | 2024-03-06 | BeiGene, Ltd. | Imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivatives as tlr7 agonist |
| EP3966222A4 (en) | 2019-05-09 | 2023-10-04 | Aligos Therapeutics, Inc. | MODIFIED CYCLIC DI-NUCLEOSIDE COMPOUNDS AS STING MODULATORS |
| CN118766947A (zh) | 2020-01-27 | 2024-10-15 | 吉利德科学公司 | 用于治疗SARS CoV-2感染的方法 |
| TWI884403B (zh) | 2020-02-18 | 2025-05-21 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI883391B (zh) | 2020-02-18 | 2025-05-11 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI874791B (zh) | 2020-02-18 | 2025-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| AR121356A1 (es) | 2020-02-18 | 2022-05-11 | Gilead Sciences Inc | Compuestos antivirales |
| TWI785528B (zh) | 2020-03-12 | 2022-12-01 | 美商基利科學股份有限公司 | 1’-氰基核苷之製備方法 |
| KR20220164784A (ko) | 2020-04-06 | 2022-12-13 | 길리애드 사이언시즈, 인코포레이티드 | 1'-시아노 치환된 카르바뉴클레오시드 유사체의 흡입 제형 |
| AU2021281351A1 (en) | 2020-05-29 | 2023-01-19 | Gilead Sciences, Inc. | Remdesivir treatment methods |
| PH12022553530A1 (en) | 2020-06-24 | 2024-06-24 | Gilead Sciences Inc | 1'-cyano nucleoside analogs and uses thereof |
| EP4228656A4 (en) | 2020-08-18 | 2024-09-04 | Yeda Research and Development Co. Ltd | ANTI-VIRAL AND ANTI-TUMOR COMPOUNDS |
| PL4200301T3 (pl) | 2020-08-24 | 2025-06-09 | Gilead Sciences, Inc. | Związki fosfolipidowe i ich zastosowania |
| ES2985995T3 (es) * | 2020-08-27 | 2024-11-08 | Gilead Sciences Inc | Compuestos y métodos para el tratamiento de infecciones víricas |
| US12274700B1 (en) | 2020-10-30 | 2025-04-15 | Accencio LLC | Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors |
| WO2022219636A1 (en) * | 2021-04-14 | 2022-10-20 | Yeda Research And Development Co. Ltd. | Anti-viral and anti-tumoral compounds, and uses thereof |
| EP4323362B1 (en) | 2021-04-16 | 2025-05-07 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| WO2022238816A1 (en) * | 2021-05-14 | 2022-11-17 | Bm Pharma Consulting Pty. Ltd | Bicyclic heterocyclic compounds for prophylaxis and treatment of viral infections |
| CA3228162A1 (en) | 2021-08-18 | 2023-02-23 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
| US20230295172A1 (en) | 2022-03-02 | 2023-09-21 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
| US20240252527A9 (en) * | 2022-04-25 | 2024-08-01 | Miracure Biotechnology Limited | Nucleoside drugs for the treatment or prevention of coronavirus infection and their uses |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816570A (en) | 1982-11-30 | 1989-03-28 | The Board Of Regents Of The University Of Texas System | Biologically reversible phosphate and phosphonate protective groups |
| US4968788A (en) | 1986-04-04 | 1990-11-06 | Board Of Regents, The University Of Texas System | Biologically reversible phosphate and phosphonate protective gruops |
| JP3347723B2 (ja) | 1990-06-13 | 2002-11-20 | グラツィエル，アーノルド | 含リンプロドラッグ |
| EP0481214B1 (en) | 1990-09-14 | 1998-06-24 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Prodrugs of phosphonates |
| US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
| DE19912636A1 (de) | 1999-03-20 | 2000-09-21 | Aventis Cropscience Gmbh | Bicyclische Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und pharmazeutische Mittel |
| EP1225899A2 (en) | 1999-11-04 | 2002-07-31 | Virochem Pharma Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
| MXPA02008078A (es) | 2000-02-18 | 2002-11-29 | Julio Javier Cristiani | Metodo para el tratamiento o prevencion de infecciones por flavivirus utilizando analogos de nucleosidos. |
| MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
| US20030008841A1 (en) | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| CA2426187C (en) | 2000-10-18 | 2011-08-16 | Pharmasset Limited | Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation |
| CN1267446C (zh) * | 2001-01-22 | 2006-08-02 | 默克公司 | 作为依赖于rna的rna病毒聚合酶的抑制剂的核苷衍生物 |
| WO2003026675A1 (en) | 2001-09-28 | 2003-04-03 | Idenix (Cayman) Limited | Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| PT1576138T (pt) | 2002-11-15 | 2017-05-03 | Idenix Pharmaceuticals Llc | 2'-metil-nucleósidos em combinação com interferão e mutação de flaviviridae |
| US8492539B2 (en) | 2004-09-14 | 2013-07-23 | Gilead Pharmasset Llc | Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives |
| US20080280842A1 (en) * | 2004-10-21 | 2008-11-13 | Merck & Co., Inc. | Fluorinated Pyrrolo[2,3-D]Pyrimidine Nucleosides for the Treatment of Rna-Dependent Rna Viral Infection |
| CN101043893A (zh) * | 2004-10-21 | 2007-09-26 | 默克公司 | 治疗RNA－依赖性RNA病毒感染的氟化吡咯并[2,3－d]嘧啶核苷 |
| TW200720285A (en) * | 2005-04-25 | 2007-06-01 | Genelabs Tech Inc | Nucleoside compounds for treating viral infections |
| WO2006121820A1 (en) | 2005-05-05 | 2006-11-16 | Valeant Research & Development | Phosphoramidate prodrugs for treatment of viral infection |
| WO2007027248A2 (en) | 2005-05-16 | 2007-03-08 | Valeant Research & Development | 3', 5' - cyclic nucleoside analogues for treatment of hcv |
| CA2627839C (en) | 2005-11-02 | 2014-08-19 | Bayer Healthcare Ag | Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| WO2008005542A2 (en) * | 2006-07-07 | 2008-01-10 | Gilead Sciences, Inc., | Antiviral phosphinate compounds |
| US20080261913A1 (en) | 2006-12-28 | 2008-10-23 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of liver disorders |
| EP2124555B1 (en) | 2007-01-05 | 2015-07-08 | Merck Sharp & Dohme Corp. | Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| NZ598927A (en) | 2007-01-12 | 2013-09-27 | Biocryst Pharm Inc | Antiviral nucleoside analogs |
| EP2125819B1 (en) | 2007-03-21 | 2014-10-22 | Bristol-Myers Squibb Company | Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases |
| PT2155758E (pt) | 2007-05-10 | 2012-11-12 | Biocryst Pharm Inc | Compostos de tetrahidrofuro[3,4-d]dioxolano para utilização no tratamento de infecções virais e do cancro |
| US8227431B2 (en) * | 2008-03-17 | 2012-07-24 | Hetero Drugs Limited | Nucleoside derivatives |
| HUE025528T2 (en) * | 2008-04-23 | 2016-05-30 | Gilead Sciences Inc | 1'-substituted carba-nucleoside analogs for antiviral treatment |
| EP2313102A2 (en) * | 2008-07-03 | 2011-04-27 | Biota Scientific Management | Bycyclic nucleosides and nucleotides as therapeutic agents |
| MX352646B (es) * | 2009-09-21 | 2017-12-04 | Gilead Sciences Inc | Analogos de carba-nucleosidos sustituidos con 2'-fluoro para tratamiento antiviral. |
| ME01528B (me) * | 2009-09-21 | 2014-04-20 | Gilead Sciences Inc | POSTUPCI l INTERMEDIJERI ZA PROIZVODNJU 1'-CIJANOKARBANUKLEOZIDIH ANALOGA |
-
2010
- 2010-09-20 MX MX2012003391A patent/MX352646B/es active IP Right Grant
- 2010-09-20 ES ES10763083.2T patent/ES2614651T3/es active Active
- 2010-09-20 AP AP2012006189A patent/AP2012006189A0/xx unknown
- 2010-09-20 PE PE2020000354A patent/PE20210668A1/es unknown
- 2010-09-20 HR HRP20170197TT patent/HRP20170197T1/hr unknown
- 2010-09-20 ME MEP-2017-35A patent/ME02656B/me unknown
- 2010-09-20 KR KR1020187000491A patent/KR20180006499A/ko not_active Ceased
- 2010-09-20 PT PT107630832T patent/PT2480552T/pt unknown
- 2010-09-20 KR KR1020127010076A patent/KR101818779B1/ko active Active
- 2010-09-20 PE PE2012000359A patent/PE20120995A1/es not_active Application Discontinuation
- 2010-09-20 JP JP2012529958A patent/JP5795766B2/ja active Active
- 2010-09-20 PE PE2016000070A patent/PE20160217A1/es unknown
- 2010-09-20 WO PCT/US2010/049471 patent/WO2011035231A1/en not_active Ceased
- 2010-09-20 NZ NZ599402A patent/NZ599402A/en unknown
- 2010-09-20 LT LTEP10763083.2T patent/LT2480552T/lt unknown
- 2010-09-20 SI SI201031372T patent/SI2480552T1/sl unknown
- 2010-09-20 RS RS20170152A patent/RS55699B1/sr unknown
- 2010-09-20 SG SG2012018883A patent/SG179194A1/en unknown
- 2010-09-20 DK DK10763083.2T patent/DK2480552T3/en active
- 2010-09-20 CR CR20190103A patent/CR20190103A/es unknown
- 2010-09-20 EA EA201200525A patent/EA201200525A1/ru unknown
- 2010-09-20 CA CA2773772A patent/CA2773772C/en active Active
- 2010-09-20 EP EP16196457.2A patent/EP3150608B1/en active Active
- 2010-09-20 SM SM20170091T patent/SMT201700091T1/it unknown
- 2010-09-20 BR BR122021012877A patent/BR122021012877B8/pt active IP Right Grant
- 2010-09-20 UA UAA201204937A patent/UA110466C2/ru unknown
- 2010-09-20 AU AU2010295373A patent/AU2010295373B2/en active Active
- 2010-09-20 CN CN201080041902XA patent/CN102596958A/zh active Pending
- 2010-09-20 EP EP10763083.2A patent/EP2480552B1/en active Active
- 2010-09-20 BR BR112012006261-1A patent/BR112012006261B1/pt active IP Right Grant
- 2010-09-20 PL PL10763083T patent/PL2480552T3/pl unknown
- 2010-09-20 HU HUE10763083A patent/HUE032252T2/en unknown
- 2010-09-20 BR BR122021021135-3A patent/BR122021021135B1/pt active IP Right Grant
- 2010-09-20 ES ES16196457T patent/ES2730805T3/es active Active
-
2012
- 2012-03-13 IL IL218599A patent/IL218599A/en active IP Right Grant
- 2012-03-21 CL CL2012000707A patent/CL2012000707A1/es unknown
- 2012-03-23 ZA ZA2012/02175A patent/ZA201202175B/en unknown
- 2012-04-17 CR CR20120186A patent/CR20120186A/es unknown
- 2012-04-19 EC ECSP12011817 patent/ECSP12011817A/es unknown
-
2015
- 2015-05-14 JP JP2015098728A patent/JP6033362B2/ja active Active
-
2016
- 2016-09-28 IL IL248110A patent/IL248110A0/en unknown
- 2016-10-24 JP JP2016207475A patent/JP2017075146A/ja not_active Withdrawn
- 2016-11-23 AU AU2016262676A patent/AU2016262676B2/en active Active
-
2017
- 2017-02-07 CY CY20171100168T patent/CY1118605T1/el unknown
- 2017-02-09 SM SM201700091T patent/SMT201700091B/it unknown
-
2018
- 2018-06-20 AU AU2018204449A patent/AU2018204449B2/en active Active
-
2020
- 2020-04-17 AU AU2020202600A patent/AU2020202600B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013505265A5 (enExample) | ||
| JP2012527477A5 (enExample) | ||
| TWI367206B (en) | Process for the preparation of prostaglandin analogues and intermediates thereof | |
| IL246265B (en) | A method for the production of intermediates for the preparation of 5-fluoro-h1-pyrazolopyridines and such compounds | |
| PL2289864T3 (pl) | Proces otrzymywania związków fluorowych | |
| EP2762166A4 (en) | ANTIGEN-BINDING MOLECULES TO PROMOTE ANTIGEN LOSS | |
| JP2013532130A5 (enExample) | ||
| JP2010241791A5 (enExample) | ||
| HUE066392T2 (hu) | Eljárás fluoralkil-fluorformiát elõállítására | |
| IL220936A0 (en) | Process for the synthesis of lacosamide | |
| EP2310347A4 (en) | PROCESS FOR THE PREPARATION OF PERFLUORATED CIS-ALKEN | |
| EP3444238A3 (en) | Process for preparing difluoromethylene compounds | |
| JP2012094862A5 (enExample) | ||
| JP2011519871A5 (enExample) | ||
| JP2010209099A5 (enExample) | ||
| IL223066A0 (en) | New process for the synthesis of tapentadol and intermediates thereof | |
| IL219913A0 (en) | New process for the preparation of tapentadol and intermediates thereof | |
| ITMI20072262A1 (it) | Procedimento per la preparazione di acido (s)(+)-3-(amminometil)-5-metilesanoico | |
| IL225557A (en) | Preparation Method (3s, 3s) 4,4'-Disulfandylbis (3-Aminobutane 1 - Sulfonic Acid) | |
| ITMI20071261A1 (it) | Procedimento per la preparazione di cinacalcet | |
| BR112012017828A2 (pt) | ''método para a produção de um produto químico por fermentação contínua'' | |
| ITBS20100012A1 (it) | Procedimento per la preparazione di fluazinam | |
| JP2013119547A5 (enExample) | ||
| JP2012250569A5 (enExample) | ||
| TWI562985B (en) | Process for the preparation of enolate salts of 4-fluoro-2-hydroxymethylene-3-oxobutyrates |